This study’s findings indicate that miR-200a-3p may have a role in the pathophysiology of AD and protect neurons from Aβ-induced toxicity through two potential mechanisms: one involves preventing Aβ overproduction by reducing BACE1 expression, and the other involves reducing tau hyperphosphorylation by reducing PKA expression. This evidence concerns the gene MAPT and Alzheimer disease.